Month: November 2023

[ad_1] Lifera Omics, newly formed Joint Venture (JV) to be based in Riyadh, Saudi Arabia, provides state-of-the-art genomic and multiomic testing services to patients, health systems, biopharma clients, and research institutions across the Gulf Cooperation Council (GCC) region CENTOGENE to receive an additional $10 million upfront JV milestone payment, following an initial… Continue reading CENTOGENE and Lifera, a Public Investment Fund (PIF) Company, Complete Strategic Joint Venture Transaction

[ad_1] All financial amounts in Canadian dollars unless stated otherwise. TORONTO, November 28, 2023–(BUSINESS WIRE)–CI Financial Corp. (“CI”) (TSX: CIX) today reported preliminary total assets of $420.7 billion as at October 31, 2023, consisting of asset management assets of $117.1 billion, Canadian wealth management assets of $80.7 billion, Canadian custody assets of $23.4 billion, and… Continue reading CI Financial Reports Total Assets of $420.7 Billion for October 2023

[ad_1] OpenText to Focus on Cloud and AI Opportunity Within Information Management WATERLOO, ON, Nov. 28, 2023 /PRNewswire/ — Open Text Corporation (NASDAQ: OTEX), (TSX: OTEX), today announced that it has reached a definitive agreement to divest its AMC business to Rocket Software, Inc., a Bain Capital portfolio company (“Rocket Software”), for US$2.275 billion in… Continue reading OpenText to Divest Application Modernization and Connectivity (AMC) Business to Rocket Software for $2.275B

[ad_1] What You Need to Know Have eligible clients signed up for Medicare medical coverage? What about drug benefits? Do the plans selected cover the doctors, hospitals and prescriptions the clients use? As the much-publicized annual Medicare enrollment period unfolds, it’s easy to overlook the needs of clients who are becoming eligible for Medicare coverage… Continue reading Helping First-Time Medicare Enrollees | ThinkAdvisor

[ad_1] WINNIPEG, Manitoba, Nov. 28, 2023 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announced its third quarter 2023 financial results. Third Quarter Financial Highlights: Revenue from product and services for the three months ended September 30, 2023 was $548,785 an increase of 29% from $425,671 in the three… Continue reading Kane Biotech Announces Improved Third Quarter 2023

[ad_1] Adam Birenbaum, chairman and CEO of Buckingham Strategic Wealth, joined the firm at age 24 as an unpaid intern. By 31, he was CEO of what would become one of the country’s largest RIAs. In an interview with ThinkAdvisor, Birenbaum looks back at leadership lessons he’s learned and a few mistakes he’s made, as… Continue reading At Buckingham, CEO Birenbaum Keeps Building